Syndax Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Michael A. Metzger, Chief Executive Officer, rings the Closing Bell.